CRISPR Therapeutics recently drew attention as updates highlighted progress in its gene-editing pipeline, including early-stage studies of CTX310, an in vivo therapy designed to lower LDL cholesterol ...

According to Precedence Research, the global gRNA market size is expected to grow from USD 708.92 million in 2025 to nearly ...

Programmable CRISPR tools are turning stem cell biology into something closer to software engineering, shrinking ...

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of ...

On November 18, 2025, ToolGen, Inc. (“ToolGen”) filed a complaint (“Complaint”) in the District of Massachusetts alleging infringement of its ...

A one-year-old baby boy has received an incredible honour, for helping researchers get one step closer to finding treatment ...

A team of researchers at the Icahn School of Medicine at Mount Sinai has uncovered why children with the same ...

Scientists have used a new type of gene therapy to cure leukaemia patients. The treatment, which uses edited immune cells ...

Technion’s highest honor recognizes Mirkin for pioneering discoveries in nanoscience, including the Spherical Nucleic Acid (SNA) technology that forms the foundation of Flashpoint’s structural ...

A groundbreaking new treatment using genome-edited immune cells, developed by scientists at UCL (University College London) ...

DeepSeek's founder and CEO, Liang Wenfeng, has been listed among the top 10 "people who shaped science in 2025" by the ...

Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.